Selima Rana M, Saleem Israa A, Shawki Mamdouh M, Darwish Amira A, Yehia Mona A, Mohamed Ehab I
Medical Biophysics Department, Medical Research Institute, Alexandria University, 165 El-Horreya Avenue, Alexandria, 5433005, Egypt.
Optometry Department, Technical Medical Institute, Erbil Polytechnic University, Erbil, Iraq.
Sci Rep. 2025 Feb 10;15(1):4942. doi: 10.1038/s41598-025-87971-z.
Obesity is a metabolic disease characterized by an imbalance between caloric intake and expenditure, leading to excess fat and increasing the risk of various health conditions. This study compares the anti-obesity effects of gold nanoparticles (AuNPs) to orlistat in an experimental model of induced obesity in Wistar Albino rats. In addition to negative and positive control rats, obese rats were treated with variable daily and weekly doses of AuNPs and daily orlistat for nine weeks. Bioelectric impedance analysis (BIA) and dissection techniques were used to indirectly and directly measure body-composition in all rat groups. Hepatic and renal function and ultrastructure were assessed by blood biochemical and histological examinations to detect treatment-related alterations. High doses of AuNPs reduced body fat, increased muscle mass, improved dyslipidemia, glycemia, and antioxidant effects in obese rats, and restored normal TG, FBG, and MDA levels by reducing obesity-related oxidative damage. Histological and ultrastructural examinations showed that these high doses repaired liver and kidney cells, and reduced fat accumulation and body weight compared to the standard treatment for obesity by orlistat.
肥胖是一种代谢性疾病,其特征在于热量摄入与消耗之间的失衡,导致脂肪过多,并增加各种健康问题的风险。本研究在Wistar白化大鼠诱导肥胖的实验模型中,比较了金纳米颗粒(AuNPs)与奥利司他的抗肥胖效果。除了阴性和阳性对照大鼠外,肥胖大鼠接受了不同的每日和每周剂量的AuNPs以及每日奥利司他治疗,为期九周。生物电阻抗分析(BIA)和解剖技术用于间接和直接测量所有大鼠组的身体成分。通过血液生化和组织学检查评估肝功能、肾功能和超微结构,以检测与治疗相关的改变。高剂量的AuNPs可减少肥胖大鼠的体脂,增加肌肉质量,改善血脂异常、血糖和抗氧化作用,并通过减少与肥胖相关的氧化损伤,使甘油三酯(TG)、空腹血糖(FBG)和丙二醛(MDA)水平恢复正常。组织学和超微结构检查表明,与奥利司他治疗肥胖的标准疗法相比,这些高剂量修复了肝细胞和肾细胞,并减少了脂肪堆积和体重。